VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GMRE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GMREGlobal Medical REIT Inc.
$35.74$94M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGMRECash Flow

Global Medical REIT Inc. (GMRE) Cash Flow Statement

14Y historyFree accessUpdated daily

Cash flow quality is severely compromised, with AFFO plummeting to -$101.4M in 2025Q4 as capital expenditure intensity reached $105.1M, far outpacing recurring cash generation.

GMRE Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Aug'14Aug'13Aug'12
Cash from Operations73.61M70.05M68.44M76.54M68.97M34.52M36.43M24.83M11.6M-2.72M-208.8K-146.26K-33.79K-35.11K
Operating CF Growth %5.09%2.35%-10.58%10.98%99.79%-5.24%46.68%114.03%526.08%-1204.19%-42.76%-332.8%3.74%-
Operating CF / Revenue %49.67%50.61%48.56%55.8%59.55%36.91%51.5%46.69%38.39%-33.7%-10.13%-38.45%--
Net Income-6.88M6.63M20.61M20M18.34M-2.5M9.59M14.56M-87K-6.35M-1.61M-652.21K-45.34K-50.11K
Depreciation & Amortization58.04M56.08M59.01M57.66M47.31M36.82M25.52M17.96M10.13M2.38M659.67K129.08K00
Stock-Based Compensation4.5M5.1M4.24M4.68M5.81M5.32M3.34M2.67M1.8M1.68M0000
Other Non-Cash Items17.95M1.01M-9.73M-4.06M1.33M1.56M1.76M1.75M1.48M350.44K126.53K26.44K11.54K15K
Working Capital Changes01.21M-5.69M-1.74M-3.82M-7.65M-3.77M-4.43M-1.71M-780.96K614.24K350.42K11.54K15K
Cash from Investing-60.4M-45.94M67.62M-137.25M-194.66M-223.67M-258.2M-151.62M-252.65M-150.36M-32.34M-21.88M00
Acquisitions (Net)00000-5.09M000-140.37K0000
Purchase of Investments0000-2.78M-1.54M0-373K-426K-797.82K-385.1K000
Sale of Investments21.47M57.62M000208K023.95M21K242.04K0000
Other Investing-81.87M-103.56M67.62M13.68M366K1.54M-3.21M5.26M-433K242.04K-32.34M-14.94K00
Cash from Financing-10.26M-21.89M-143.79M62.41M127.7M192.72M224.11M124.51M226.49M163.57M41.64M22.19M25K0
Dividends Paid-52.31M-65.69M-64.85M-64.24M-58.32M-45.77M-34.99M-24.79M-15.98M-3.88M-255.6K-42.62K00
Common Dividends0-59.87M-59.02M-58.42M-52.5M-39.94M-29.17M-18.96M-15.23M-3.88M-256K-42.62K00
Debt Issuance (Net)01000K-1000K1000K-1000K1000K1000K1000K1000K1000K1000K1000K00
Share Repurchases-6M000000-263K000000
Other Financing42.05M252K7.15M-5.19M-8.89M-2.83M-1.33M-3.1M-3.06M-2.9M-389.14K19.58M00
Net Change in Cash2.95M2.22M-7.73M1.7M2.01M3.57M2.34M-2.27M-14.56M10.49M9.1M159.47K-8.79K-35.11K
Exchange Rate Effect00000000000000
Cash at Beginning8.94M6.72M14.46M12.76M10.75M7.18M4.84M7.11M19.67M9.18M88.81K3.52K12.31K47.42K
Cash at End11.89M8.94M6.72M14.46M12.76M10.75M7.18M4.84M5.11M19.67M9.18M162.99K3.52K12.31K
Free Cash Flow73.61M-25.07M58.39M-79.66M-132.69M-184.27M-220.38M-156M-240.62M-153.18M-32.41M-22.01M-33.79K-35.11K
FCF Growth %393.58%-142.94%173.3%39.97%27.99%16.39%-41.27%35.17%-57.08%-372.6%-47.24%-65039.74%3.74%-
FCF / Revenue %49.67%-18.12%41.43%-58.08%-114.58%-197.04%-311.6%-293.28%-796.14%-1895.93%-1572.15%-5786.81%--

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowDeteriorating
Top Statement Risk

Unsustainable dividend payout coverage

Dividend Coverage Remains Severely Compromised

According to the company's quarterly financial disclosures, the dividend payout ratio relative to AFFO reached an alarming 414% in 2025Q4, indicating that the current distribution is not supported by recurring cash flow and may necessitate a strategic re-evaluation of the company's capital return policy.

The persistent negative AFFO figures suggest that the REIT is currently unable to fund its dividend from operations after accounting for necessary maintenance capital and leasing costs. Investors should monitor whether management continues to utilize external financing to bridge this widening gap, as such reliance on debt or equity issuance to fund distributions is rarely sustainable over the long term.

Depreciation Masks Underlying Cash Erosion

As reported in recent SEC filings, the divergence between GAAP net income and FFO highlights a significant distortion, with FFO/NI ratios reaching -1.84 in 2025Q4, suggesting that non-cash accounting charges are failing to capture the true economic reality of the company's deteriorating cash-generating capacity.

While REITs typically use FFO to normalize for depreciation, the extreme volatility in this metric for GMRE implies that the underlying asset performance is being obscured by accounting adjustments. This disconnect warrants further investigation into whether the reported FFO is truly representative of the cash available to shareholders or if it is being inflated by non-recurring items.

Capital Expenditure Intensity Escalates Rapidly

Based on the provided financial statements, capital expenditures surged to -$105.1M in 2025Q4, a substantial increase that appears to be placing immense pressure on the company's liquidity and further distancing the firm from achieving a self-funding status for its property-level maintenance and tenant improvement requirements.

The significant spike in capital outflows suggests that the portfolio may require more intensive reinvestment than previously anticipated, potentially due to aging facilities or competitive pressures to retain tenants. This level of spending appears to be a primary driver of the negative AFFO, raising questions about the long-term yield profile of the existing asset base.

Operating Cash Flow Quality Weakens

Financial data indicates that while GAAP operating cash flow remained positive at $21.6M in 2025Q4, the quality of these earnings is questionable when contrasted with the massive capital expenditure requirements that effectively negate the REIT's ability to generate meaningful free cash flow for its investors.

The reliance on operating cash flow to cover both massive capex and dividend payments appears increasingly precarious given the current trajectory. Analysts should monitor whether the company's operational cash generation can stabilize without further dilutive financing, as the current trend suggests a structural mismatch between cash inflows and the capital intensity of the portfolio.

GMRE — Frequently Asked Questions

Quick answers to the most common questions about buying GMRE stock.

How much cash does Global Medical REIT Inc. (GMRE) generate from operations?

Global Medical REIT Inc. (GMRE) generated $73.6M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Global Medical REIT Inc.'s free cash flow?

Global Medical REIT Inc. (GMRE) generated $73.6M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Global Medical REIT Inc.'s capital expenditure (CapEx)?

Global Medical REIT Inc. (GMRE) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Global Medical REIT Inc. distribute cash to shareholders?

In 2025, Global Medical REIT Inc. (GMRE) returned $52.3M to shareholders via cash dividends and spent $6.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.